Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment

 

Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  

Search:

Biotechnology Headlines from PR Newswire


New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing
Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring
Viruses' Advantage of Surprise is Lost
TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014
BioSpecifics Technologies Corp. Announces New Data on XIAFLEX® for Peyronie's Disease Presented at SMSNA Scientific Meeting
Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015
PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award
Orexigen Announces Allowance of New U.S. Patent for Contrave® (naltrexone HCl / bupropion HCl extended release)
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe
Abaxis Acquires UK-based Distribution Organization
EDDA Technology Introduces the Newly FDA-Cleared IQQA®-BodyImaging and Cloud-Based OnDemand Services for Imaging-Guided Cancer Treatment
Oncology Biosimilars Market to Grow at 29.87% CAGR to 2018
Lexicon Announces Pricing Of Convertible Senior Notes Offering
Lexicon Announces Pricing Of Common Stock Offering
Coqui RadioPharmaceuticals Inks Deal With INVAP
Biorem Reports Third Quarter Results
Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast
SGI-DNA Launches Gibson Assembly® HiFi 1 Step Kit for Simple, Seamless and Rapid Construction of Synthetic Genes, Gene Clusters and Genetic Pathways
Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma
Western Refining raises more than $595,000 for St. Jude Children's Research Hospital® during 'spooktacular' Halloween promotion
CinchView™ Decodes Lab Results
Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program
Seven Steps to Reducing Pressure Ulcers
Cognizant Completes Acquisition of TriZetto, Creating a Fully-Integrated Healthcare Technology and Operations Leader
BioInformatics LLC Announces the Winners of the 2014 Life Science Industry Awards
Global Cell and Tissue Analysis Products Market 2014-2018
Benefunder Explores Role of Philanthropy in Fueling Innovation During World Stem Cell Summit
Heptares Orphan Disease Programme Awarded Grant from the UK Biomedical Catalyst
PharmAthene Fulfills Valortim® IDIQ Contract
Altair Partners with South Africa's Centre for High Performance Computing
Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock
Beactica Awarded Funding to Develop Epigenetic Cancer Drugs
ViaCyte to Present at 26th Annual Piper Jaffray Healthcare Conference
Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on December 4
Organovo to Present at the 26th Annual Piper Jaffray Healthcare Conference
Abera Bioscience AB - Product Pipeline Review - 2014
Fred Hutch recruits D. Gary Gilliland as its new president and director
Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer
Clinic-developed software to support NIH/NCATS global rare diseases registry
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting
Spherix Comments on Pending Settlement Between Cisco and Rockstar Consortium
Apellis Pharmaceuticals to acquire Potentia Pharmaceuticals.
Camurus and Braeburn Pharmaceuticals sign exclusive license for long-acting buprenorphine injectables for the treatment of opioid dependence and pain
Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock
Imagenetix, Inc. Reports September 30, 2014 Results
Lexicon Announces Proposed Common Stock Offering
Microbial Robotics' New Genetics Rights Management Product Platform Enters International Markets with Patent Filing
NW BIO ANNOUNCES FINANCINGS TOTALING $35 MILLION TO EXPAND AND ACCELERATE DCVAX®-L AND DCVAX®-DIRECT PROGRAMS
MabVax Therapeutics And Memorial Sloan-Kettering Cancer Center Report on Potential Use of Dual-Labeled Antibody To Detect and Guide Surgical Removal of Pancreatic Cancer
Regenicin Enters Into Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

< Prev Next >
PR Newswire - United Business Media
 



Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.